mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.8 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |